Combined radiation and immune checkpoint inhibitor therapy for metastatic or recurrent hepatocellular carcinoma: a real-world study of 108 patients

Combined radiation and immune checkpoint inhibitor therapy for metastatic or recurrent hepatocellular carcinoma: a real-world study of 108 patients

BackgroundThe prognosis of metastatic or recurrent hepatocellular carcinoma (HCC) remains poor, and new treatment strategies are warranted. Despite promising preclinical results demonstrating that radiation primes the immune system and produces a synergistic antitumor response for long-term disease...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Yirui Zhai, Yefan Zhang, Fan Wu, Jianguo Zhou, Lingxia Xin, Feng Ye, Wei Sun, Huiying Zeng, Yan Song, Yongkun Sun, Wen Zhang, Shu-Lian Wang, Yuan Tang, Hui Fang, Pan Zhao, Yueping Liu, Ningning Lu, Shunan Qi, Hao Jing, Wenwen Zhang, Yongwen Song, Ye-Xiong Li, Liming Wang, Bo Chen
Формат: Статья
Язык:английский
Опубликовано: Frontiers Media S.A. 2025-08-01
Серии:Frontiers in Immunology
Предметы:
hepatocellular carcinoma
radiotherapy
immunotherapy
immune checkpoint inhibitor
PD-1/PD-L1 inhibitor
Online-ссылка:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1594577/full
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!
Логин Для информации по задолженностям и напоминаниям

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1594577/full

Схожие документы